In: pharmaceutical outsourcing
There are as many ways to create in vivo proposals on the Scientist.com marketplace as there are researchers to request them, so how do we ensure that all requests are being compared equally? Scientist.com has streamlined the process by enabling side-by-side comparisons of proposals across multiple vendors based on key indicators such as quality, price, supplier rating and turnaround time.Read More
02 Apr, 2019Tissue Processing in the 21st Century: How can I incorporate innovative techniques to make my histology workflow easier and more reliable?
Breathtaking progress in life sciences has brought us innovations such as high-throughput and individually affordable genomic sequencing as well as next-generation flow cytometry that can phenotype dissociated cells for their expression of dozens of markers simultaneously.Read More
In part I we examined the evolution of outsourcing in drug discovery. In part II we will examine with deeper focus the specific reasons why it is beneficial to outsource scientific experiments. Research organizations and even individual researchers outsource for a variety of reasons, but here are just a few.Read More
A recent white paper was released that traces the trajectory over the last ten years of 120 independent for-profit startups in the field of research workflows and scholarly communication. The author, Yvonne Campfens, presented the report at the Academic Publishing in Europe (APE) Conference held January 15-16, 2019 in Berlin.Read More
Luke Timmerman recently posted a nice blog at Xconomy talking about the poor public perception of the pharmaceutical industry and what the industry…Read More